Literature DB >> 26880328

Clinical Outcomes and Costs Within 90 Days of Primary or Revision Total Joint Arthroplasty.

Christine I Nichols1, Joshua G Vose1.   

Abstract

BACKGROUND: This study evaluated the factors and costs associated with discharge destination and readmission, within 90 days of surgery, for primary or revision total knee arthroplasty (TKA) and total hip arthroplasty (THA).
METHODS: This retrospective database analysis used health care claims from the Truven MarketScan Database (2009-2013). Patients were selected if aged ≥18 years, with continuous health plan enrollment from 3-month baseline through 3-month follow-up. Logistic regression and Cox proportional hazard models were used to analyze factors associated with discharge destination and risk of readmission. Total 90-day costs were calculated for different patient pathways of care, dependent on complications, discharge destination, and readmission status.
RESULTS: A total of 323,803 primary TKA, 25,354 revision TKA, 159,390 primary THA, and 17,934 revision THA cases met selection criteria. All-cause complications occurred in 2.5%, 37.2%, 2.6%, and 35.0% of each cohort. Complications, transfusions, and length of stay ≥3 days were associated with greater odds of discharge to home with home health services or skilled nursing facility (SNF) vs home under self-care (P < .001 all cohorts), whereas discharge to home with home health services or SNF was associated with greater risk of readmission (P < .05 for all cohorts except one). The ratio of total 90-day costs for the highest- (revision, SNF, readmission) vs lowest-cost (primary, home under self-care, no readmission) care pathways ranged from 1.8 to 2.2.
CONCLUSION: As Medicare payment policy for total joint arthroplasty shifts toward bundling, an awareness of factors associated with outlier costs will be requisite to remain profitable.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cost burden; Post–acute care; Readmission; Risk factors; Total joint arthroplasty

Mesh:

Year:  2016        PMID: 26880328     DOI: 10.1016/j.arth.2016.01.022

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  45 in total

1.  Are Bundled Payments a Viable Reimbursement Model for Revision Total Joint Arthroplasty?

Authors:  P Maxwell Courtney; Blair S Ashley; Eric L Hume; Atul F Kamath
Journal:  Clin Orthop Relat Res       Date:  2016-06-29       Impact factor: 4.176

Review 2.  Review article: Patient characteristics that act as risk factors for intraoperative complications in hip, knee, and shoulder arthroplasties.

Authors:  Adel Hijazi; Muhammad Talha Padela; Zain Sayeed; Aws Hammad; Kamela Devole; Todd Frush; Gamal Mostafa; Walid K Yassir; Khaled J Saleh
Journal:  J Orthop       Date:  2019-06-17

3.  What Factors are Associated With 90-day Episode-of-care Payments for Younger Patients With Total Joint Arthroplasty?

Authors:  Shweta Pathak; Cecilia M Ganduglia; Samir S Awad; Wenyaw Chan; John M Swint; Robert O Morgan
Journal:  Clin Orthop Relat Res       Date:  2017-07-13       Impact factor: 4.176

4.  What is the Long-term Economic Societal Effect of Periprosthetic Infections After THA? A Markov Analysis.

Authors:  Thomas J Parisi; Joseph F Konopka; Hany S Bedair
Journal:  Clin Orthop Relat Res       Date:  2017-04-07       Impact factor: 4.176

5.  Readmission Rates and Diagnoses Following Total Hip Replacement in Relation to Insurance Payer Status, Race and Ethnicity, and Income Status.

Authors:  Robert S White; Dahniel L Sastow; Licia K Gaber-Baylis; Virginia Tangel; Andrew D Fisher; Zachary A Turnbull
Journal:  J Racial Ethn Health Disparities       Date:  2018-02-12

6.  Role of arthroplasty in the Jehovah's Witness population.

Authors:  Jay L Mottla; Jordan P Murphy; Laura E Keeling; Richard Verstraete; Mark W Zawadsky
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-01-03

7.  Intraoperative hemorrhage in revision total hip arthroplasty: a retrospective single-center study.

Authors:  Kana Saito; Yu Kaiho; Toru Tamii; Tadaho Nakamura; Eri Kameyama; Masanori Yamauchi
Journal:  J Anesth       Date:  2019-04-29       Impact factor: 2.078

8.  Outcomes Over 90-Day Episodes of Care in Medicare Fee-for-Service Beneficiaries Receiving Joint Arthroplasty.

Authors:  Addie Middleton; Yu-Li Lin; James E Graham; Kenneth J Ottenbacher
Journal:  J Arthroplasty       Date:  2017-03-30       Impact factor: 4.757

9.  Predictors and Cost of Readmission in Total Knee Arthroplasty.

Authors:  Kenneth L Urish; Yongmei Qin; Benjamin Y Li; Tudor Borza; Michael Sessine; Peter Kirk; Brent K Hollenbeck; Jonathan E Helm; Mariel S Lavieri; Ted A Skolarus; Bruce L Jacobs
Journal:  J Arthroplasty       Date:  2018-04-17       Impact factor: 4.757

10.  Projections and Epidemiology of Revision Hip and Knee Arthroplasty in the United States to 2030.

Authors:  Andrew M Schwartz; Kevin X Farley; George N Guild; Thomas L Bradbury
Journal:  J Arthroplasty       Date:  2020-02-19       Impact factor: 4.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.